The maker of a permanent contraceptive implant subject to thousands of injury reports from women and repeated safety restrictions by regulators said Friday that it will stop selling the device in the U.S.
Catholic officials, ethicists and observers said the rules approved by U.S. bishops last month could toughen church scrutiny of merger or partnership agreements, notably the pending huge merger of Catholic Health Initiatives and Dignity Health.
HHS is taking steps to remove legal protections for drug rebates that favor pharmacy benefit managers. It’s unclear whether the changes will actually lead to lower drug prices, experts say.
Anthem’s policy led to a big spike in coverage denials among ED patients in three states last year, according to a senator’s report. But Anthem ended up reversing the majority of denied claims that patients appealed.
The CMS sent a rule to the White House for review that may resume risk-adjustment payments to insurers. Patient advocates have claimed the agency was trying to sabotage the insurance exchanges by eliminating billions in payments.
Consumers can now sign a petition that lobbies Maryland providers and insurers to reveal their costs via the state’s updated price transparency website.
The 1.4 million Californians who buy coverage on the state’s individual insurance exchange will pay more in 2019 in part because the federal government zeroed out the federal penalty for not enrolling in coverage.
The 1.4 million Californians who buy coverage on the state’s individual insurance exchange will pay more in 2019 in part because the federal government zeroed out the federal penalty for not enrolling in coverage.
The Pennsylvania Supreme Court reversed a lower court’s ruling that UPMC had to cover Highmak Medicare Advantage members in-network through 2019, marking the end of a long-standing feud between the state’s largest health system and insurer.